Drug or treatment

Tafolecimab clinical trials

• 2Clinical trials
• 1Country

All recruiting trials (2)

• First-line immunotherapy plus chemotherapy in extensive-stage small cell lung cancer

  This study tests whether adding Tafolecimab and Sintilimab to standard chemotherapy can help people with extensive-stage small cell lung cancer.

  Recruiting at 4 sites Phase 2 Second Affiliated Hospital, Zhejiang University, School of Medicine · Changsha, Hunan and 4 other locations · NCT07061535

• Combining Tafolecimab and Sintilimab with Chemotherapy for Advanced Lung Cancer

  This study is testing if combining two new drugs, Tafolecimab and Sintilimab, with chemotherapy can help people with advanced lung cancer who haven't had success with other treatments.

  Recruiting Phase 2 Beijing Chest Hospital, Capital Medical University · Beijing, Beijing Municipality · NCT06421298

Quick answers

How many clinical trials of Tafolecimab are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →